The 160,000 square-foot facility will allow Sugar Land, Texas-based QuVa Pharma to expand its services to hospitals in the eastern half of the U.S.
The company currently owns two FDA-approved manufacturing facilities in Texas.
QuVa Pharma plans to hire more than 100 employees once the facility is operational in mid-2017.
Financial terms of the transaction were not disclosed.
More articles on supply chain:
FDA turns to banned factory to prevent cancer drug shortages
7 latest FDA approvals
Supply chain tip of the week: Don’t underestimate the power of tidbits and newsletters
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
